By Elizabeth Chapin University of Kentucky The University of Kentucky Markey Cancer Center has treated the first patient in ...

Prayagraj: A team of researchers from Allahabad University has developed 5 new compounds that could pave the way for more effective cancer medicines.\".

The early-stage clinical trial marks the first U.S. testing of Alveltamig, an immunotherapy designed to help the immune ...

Dr. Kellie Smith discusses T-cell immunology, lung cancer immunotherapy, MANASCORE, multi-omics research, and navigating today's scientific climate.

Respiratory and sleep medicine physicians share collaborative measures to diagnose and treat comorbid sleep disorders and ...

The University of Kentucky Markey Cancer Center has treated the first patient in the U.S. with a new immunotherapy for small ...

Chronic lung infections pose a disproportionate threat to older adults, yet the biological mechanisms behind age-specific ...

Researchers reconstruct the spatial spread of pandemic respiratory viruses across metropolitan areas throughout the United ...

Abstract: Neoadjuvant immunotherapy is an emerging treatment for lung cancer. However, its efficacy varies significantly due to the complexity of the immune microenvironment, and there is a lack of ...

A new mRNA therapy that prompts the body to produce bacteria-killing ‘peptibodies’ has shown early success in preclinical models, offering a potential new tool in the fight against ...

Cancer screenings exist to try to detect the disease in its earlier stages, and ultimately to save lives. But screenings for lung cancer—the leading cause of cancer deaths worldwide—are narrow, and ...